NCT00103051View on ClinicalTrials.gov

Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2005

Conditions
Lung Cancer
Interventions
DRUG

cisplatin

DRUG

gefitinib

DRUG

gemcitabine hydrochloride

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (1)

Unknown

Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00103051 - Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter